Position in SIGA
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$102,329
-$20,818 QoQ
Shares Held
19,127
-5.1% QoQ
Ownership
0.027%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SIGA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026EP Wealth Advisors, LLC holds $31,020,308 across 10 Drug Manufacturers - Specialty & Generic names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
392,719 | $28,220,787 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
1,044 | $565,670 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
2,749 | $463,316 | |
| 4 | TRLV |
Trulieve Cannabis Corp.
|
38,555 | $378,995 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
9,464 | $320,640 | |
| 6 | ALKS |
Alkermes plc.
|
5,489 | $287,623 | |
| 7 | VTRS |
Viatris Inc
|
17,301 | $274,739 | |
| 8 | TAK |
Takeda Pharmaceutical Co Ltd
|
14,674 | $235,224 |
All Filings in SIGA
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $102,329 | 19,127 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $123,147 | 20,155 | Shares | Sole | 2026-02-18 | |
| 2025-06-30 | $128,489 | 19,707 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $109,698 | 20,018 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $83,460 | 13,887 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $81,891 | 12,132 | Shares | Sole | 2024-11-15 | |
| No filing history on record for this holder in this stock. | ||||||